| Accuray Incorporated | (NQ: ARAY) |
|
USD
|
|
Official Closing Price
/ Updated: /
|
| View: | Quote | Chart | News | SEC Filings |
(ARAY) Community Analysis from
Bulls REASONS TO BUY
|
93%
agree
15 votes
|
Best of breed stereotactic robotic radiosurgery system for cancer treatments |
|
100%
agree
1 votes
|
Long-term secular growth story |
Bears REASONS TO SELL
May 21, 2013
(Wax Ink,
3/25/13)
Texas (Mar. 25, 2013)
Wax Ink has issued a No Investment Interest rating for Accuray Incorporated (Nasdaq: ARAY) based on a recent baseline equity review which placed fair value between...(read more)
(Stock Blog Hub,
11/6/12)
Renowned radiosurgery systems maker, Accuray Incorporated (ARAY) recently received the U.S. Food and Drug Administration (“FDA”) 510(k) approval for its new Cybernife M6 Series. This...(read more)
(Stock Blog Hub,
7/11/11)
Leading radiosurgery systems maker Accuray Incorporated (ARAY) has presented encouraging new clinical data highlighting the benefits of its popular CyberKnife...(read more)
Accuray (ARAY) Company Overview
There is no analysis for ARAY yet. But you can go to Wikinvest to help create one!
